What is PhosLo primarily used for?

PhosLo is primarily used for phosphate binding, making it particularly effective for patients with chronic kidney disease (CKD) who experience elevated levels of phosphate in their blood. When the kidneys are not functioning properly, they are unable to excrete phosphate effectively, leading to hyperphosphatemia. PhosLo contains calcium acetate, which binds to dietary phosphate in the gastrointestinal tract, forming insoluble calcium phosphate, thus reducing the absorption of phosphate into the bloodstream.

By administering PhosLo, healthcare providers can help manage phosphate levels in patients, preventing potential complications such as cardiovascular issues and bone disease associated with increased phosphate levels. This pharmacological action is crucial in managing patients on dialysis or those with CKD, but the primary mechanism revolves around its role as a phosphate binder, which directly addresses the issue of elevated phosphate levels.